JP2022542445A5 - - Google Patents

Info

Publication number
JP2022542445A5
JP2022542445A5 JP2022506465A JP2022506465A JP2022542445A5 JP 2022542445 A5 JP2022542445 A5 JP 2022542445A5 JP 2022506465 A JP2022506465 A JP 2022506465A JP 2022506465 A JP2022506465 A JP 2022506465A JP 2022542445 A5 JP2022542445 A5 JP 2022542445A5
Authority
JP
Japan
Prior art keywords
dpb1
amino acid
residue corresponding
acid residue
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542445A (ja
JP7724203B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/057176 external-priority patent/WO2021019476A1/en
Publication of JP2022542445A publication Critical patent/JP2022542445A/ja
Publication of JP2022542445A5 publication Critical patent/JP2022542445A5/ja
Priority to JP2025130081A priority Critical patent/JP2025166836A/ja
Application granted granted Critical
Publication of JP7724203B2 publication Critical patent/JP7724203B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506465A 2019-07-30 2020-07-29 T細胞受容体を識別する方法 Active JP7724203B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025130081A JP2025166836A (ja) 2019-07-30 2025-08-04 T細胞受容体を識別する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962880492P 2019-07-30 2019-07-30
US62/880,492 2019-07-30
US202063029103P 2020-05-22 2020-05-22
US63/029,103 2020-05-22
PCT/IB2020/057176 WO2021019476A1 (en) 2019-07-30 2020-07-29 Methods of identifying t cell receptors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025130081A Division JP2025166836A (ja) 2019-07-30 2025-08-04 T細胞受容体を識別する方法

Publications (3)

Publication Number Publication Date
JP2022542445A JP2022542445A (ja) 2022-10-03
JP2022542445A5 true JP2022542445A5 (enExample) 2023-08-08
JP7724203B2 JP7724203B2 (ja) 2025-08-15

Family

ID=74228602

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022506465A Active JP7724203B2 (ja) 2019-07-30 2020-07-29 T細胞受容体を識別する方法
JP2025130081A Pending JP2025166836A (ja) 2019-07-30 2025-08-04 T細胞受容体を識別する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025130081A Pending JP2025166836A (ja) 2019-07-30 2025-08-04 T細胞受容体を識別する方法

Country Status (11)

Country Link
US (1) US20220291215A1 (enExample)
EP (1) EP4004546A4 (enExample)
JP (2) JP7724203B2 (enExample)
KR (1) KR20220052941A (enExample)
CN (1) CN114761802B (enExample)
AU (1) AU2020321710A1 (enExample)
CA (1) CA3146290A1 (enExample)
IL (1) IL290226A (enExample)
MX (1) MX2022001204A (enExample)
TW (1) TW202118779A (enExample)
WO (1) WO2021019476A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113795583B (zh) 2019-03-04 2026-03-27 大学健康网络 T细胞受体及其使用方法
WO2021019473A1 (en) 2019-07-30 2021-02-04 University Health Network Mhc class ii molecules and methods of use thereof
WO2021019475A1 (en) * 2019-07-30 2021-02-04 University Health Network Mhc class ii molecules and methods of use thereof
CN118662607A (zh) * 2023-03-15 2024-09-20 中国科学院上海巴斯德研究所 抑制过激炎性反应的蛋白及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012120488A (ja) * 2010-12-09 2012-06-28 Univ Of Tokyo 新規安定化組換えmhcタンパク質
MX2020003117A (es) * 2017-09-20 2020-08-20 Us Health Receptores de celulas t restringidas a hla de clase ii contra ras mutado.

Similar Documents

Publication Publication Date Title
Uhr et al. Organization of the Immune Response Genes: . Both subunits of murine IA and IE/C molecules are encoded within the I region.
EP3615565B1 (en) Tcr and peptides
Choo The HLA system: genetics, immunology, clinical testing, and clinical implications
Steinmetz et al. Genes of the major histocompatibility complex in mouse and man
Kropshofer et al. Editing of the HLA‐DR‐peptide repertoire by HLA‐DM.
JP2022162047A5 (enExample)
CN114502580B (zh) Mhc ii类分子及其使用方法
JP2022542448A5 (enExample)
Rammensee Antigen presentation–recent developments
Smith et al. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells
CN114761802B (zh) 鉴定t细胞受体的方法
EP4387644A2 (en) Peptide-hla-b*35 libraries, associated compositions, and associated methods of use
JP2022523024A5 (enExample)
JP2023534241A5 (enExample)
Reinsmoen et al. Structural model for T-cell recognition of HLA class II—associated alloepitopes
Clayberger et al. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes.
Wang et al. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors
EP4106790A1 (en) Yeast display libraries, associated compositions, and associated methods of use
Balas et al. Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA‐C null allele, Cw* 0409 N
Bade-Doeding et al. A single amino-acid polymorphism in pocket A of HLA-A* 6602 alters the auxiliary anchors compared with HLA-A* 6601 ligands
McMichael Cytotoxic T lymphocytes: specificity, surveillance, and escape
Mizuki et al. Role of HLA and T lymphocytes in the immune response
CA3223471A1 (en) Method of characterizing the binding characteristics between a peptide of interest and mhc molecules
JP2023535366A5 (enExample)
Dupont The HLA system: An introduction